Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

A new skin cancer can develop where shingles once occurred.

ZD1839 can cause skin issues like acne and hair changes.

Basal cell carcinoma may originate from vellus hair cysts.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

The treatment combination is effective and generally safe for lung cancer.

PAON shows skin patterns due to genetic mosaicism.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

Neutrophils quickly respond to skin injury.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Basal cell carcinoma behaves like hair follicles and targeting specific pathways may help treat it.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

BTNL2 helps protect hair follicles from immune attacks.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.